2,687
Views
15
CrossRef citations to date
0
Altmetric
Theory and Methods

Toward Better Practice of Covariate Adjustment in Analyzing Randomized Clinical Trials

, , &
Pages 2370-2382 | Received 27 Sep 2020, Accepted 20 Feb 2022, Published online: 27 Mar 2022

References

  • Baldi Antognini, A., and Zagoraiou, M. (2015), “On the Almost Sure Convergence of Adaptive Allocation Procedures,” Bernoulli Journal, 21, 881–908. DOI: 10.3150/13-BEJ591.
  • Bugni, F. A., Canay, I. A., and Shaikh, A. M. (2018), “Inference Under Covariate-Adaptive Randomization,” Journal of the American Statistical Association, 113, 1784–1796. DOI: 10.1080/01621459.2017.1375934.
  • Bugni, F. A., Canay, I. A., and Shaikh, A. M. (2019), “Inference Under Covariate-Adaptive Randomization with Multiple Treatments,” Quantitative Economics, 10, 1747–1785. DOI: 10.3982/QE1150.
  • Cassel, C. M., Särndal, C. E., and Wretman, J. H. (1976), “Some Results on Generalized Difference Estimation and Generalized Regression Estimation for Finite Populations,” Biometrika, 63, 615–620. DOI: 10.1093/biomet/63.3.615.
  • Chong, A., Cohen, I., Field, E., Nakasone, E., and Torero, M. (2016), “Iron Deficiency and Schooling Attainment in Peru,” American Economic Journal: Applied Economics, 8, 222–255. DOI: 10.1257/app.20140494.
  • Ciolino, J. D., Palac, H. L., Yang, A., Vaca, M., and Belli, H. M. (2019), “Ideal vs. Real: A Systematic Review on Handling Covariates in Randomized Controlled Trials,” BMC Medical Research Methodology, 19.
  • EMA (2015), Guideline on Adjustment for Baseline Covariates in Clinical Trials. Committee for Medicinal Products for Human Use, European Medicines Agency (EMA).
  • FDA (2021), Adjusting for Covariates in Randomized Clinical Trials for Drugs and Biological Products. Draft Guidance for Industry. Center for Drug Evaluation and Research and Center for Biologics Evaluation and Research, Food and Drug Administration (FDA), U.S. Department of Health and Human Services.
  • Freedman, D. A. (2008a), “On Regression Adjustments in Experiments with Several Treatments,” Annals of Applied Statistics, 2, 176–196.
  • Freedman, D. A. (2008b), “Randomization does not Justify Logistic Regression,” Statistical Science, 23, 237–249.
  • Fuller, W. A. (2009), Sampling Statistics, New York: Wiley.
  • Guo, K., and Basse, G. (2021), “The Generalized Oaxaca-blinder Estimator,” Journal of the American Statistical Association, 116, 1–13. DOI: 10.1080/01621459.2021.1941053.
  • Han, B., Enas, N. H., and McEntegart, D. (2009), “Randomization by Minimization for Unbalanced Treatment Allocation,” Statistics in Medicine, 28, 3329–3346. DOI: 10.1002/sim.3710.
  • Hu, F., and Zhang, L.-X. (2020), “On the Theory of Covariate-Adaptive Designs.” arXiv preprint arXiv:2004.02994.
  • Huber, P. J. (1967), “The Behavior of Maximum Likelihood Estimates Under Nonstandard Conditions,” in Proceedings of the Fifth Berkeley Symposium on Mathematical Statistics and Probability (Vol. 1), pp. 221–233. University of California Press.
  • International Council for Harmonisation (ICH E9) (1998), Statistical Principles for Clinical Trials E9, Geneva: Author.
  • Juszczak, E., Altman, D. G., Hopewell, S., and Schulz, K. (2019), “Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the Consort 2010 Statement,” JAMA, 321, 1610–1620. DOI: 10.1001/jama.2019.3087.
  • Kuznetsova, O. M., and Johnson, V. P. (2017), “Approaches to Expanding the Two-Arm Biased Coin Randomization to Unequal Allocation while Preserving the Unconditional Allocation Ratio,” Statistics in Medicine, 36, 2483–2498. DOI: 10.1002/sim.7290.
  • Li, X., and Ding, P. (2020), “Rerandomization and Regression Adjustment,” Journal of the Royal Statistical Society, Series B, 82, 241–268. DOI: 10.1111/rssb.12353.
  • Li, X., Ding, P., and Rubin, D. B. (2018), “Asymptotic Theory of Rerandomization in Treatment–Control Experiments,” Proceedings of the National Academy of Sciences, 115, 9157–9162. DOI: 10.1073/pnas.1808191115.
  • Lin, W. (2013), “Agnostic Notes on Regression Adjustments to Experimental Data: Reexamining Freedman’s Critique,” Annals of Applied Statistics, 7, 295–318.
  • Liu, H., and Yang, Y. (2020), “Regression-Adjusted Average Treatment Effect Estimates in Stratified Randomized Experiments,” Biometrika, 107, 935–948. DOI: 10.1093/biomet/asaa038.
  • Ma, W., Hu, F., and Zhang, L. (2015), “Testing Hypotheses of Covariate-Adaptive Randomized Clinical Trials,” Journal of the American Statistical Association, 110, 669–680. DOI: 10.1080/01621459.2014.922469.
  • Ma, W., Qin, Y., Li, Y., and Hu, F. (2020a), “Statistical Inference for Covariate-Adaptive Randomization Procedures,” Journal of the American Statistical Association, 115, 1488–1497. DOI: 10.1080/01621459.2019.1635483.
  • Ma, W., Tu, F., and Liu, H. (2020b), “Regression Analysis for Covariate-Adaptive Randomization: A Robust and Efficient Inference Perspective.” arXiv preprint arXiv:2009.02287.
  • MacKinnon, J. G., and White, H. (1985), “Some Heteroskedasticity-Consistent Covariance Matrix Estimators with Improved Finite Sample Properties,” Journal of Econometrics, 29, 305–325. DOI: 10.1016/0304-4076(85)90158-7.
  • Moore, K. L., and van der Laan, M. J. (2009), “Covariate Adjustment in Randomized Trials with Binary Outcomes: Targeted Maximum Likelihood Estimation,” Statistics in Medicine, 28, 39–64. DOI: 10.1002/sim.3445.
  • Pocock, S. J., and Simon, R. (1975), “Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial,” Biometrics, 31, 103–115. DOI: 10.2307/2529712.
  • Rosenblum, M., and van der Laan, M. J. (2010), “Simple, Efficient Estimators of Treatment Effects in Randomized Trials Using Generalized Linear Models to Leverage Baseline Variables,” The International Journal of Biostatistics, 6. DOI: 10.2202/1557-4679.1138.
  • Särndal, C.-E., Swensson, B., and Wretman, J. (2003), Model Assisted Survey Sampling, New York: Springer.
  • Shao, J. (2021), “Inference for Covariate-Adaptive Randomization: Aspects of Methodology and Theory,” (with discussions), Statistical Theory and Related Fields, 5, 172–186. DOI: 10.1080/24754269.2021.1871873.
  • Shao, J., and Wang, S. (2014), “Efficiency of Model-Assisted Regression Estimators in Sample Surveys,” Statistica Sinica, 24, 395–414. DOI: 10.5705/ss.2012.064.
  • Shao, J., and Yu, X. (2013), “Validity of Tests Under Covariate-Adaptive Biased Coin Randomization and Generalized Linear Models,” Biometrics, 69, 960–969. DOI: 10.1111/biom.12062.
  • Shao, J., Yu, X., and Zhong, B. (2010), “A Theory for Testing Hypotheses Under Covariate-Adaptive Randomization,” Biometrika, 97, 347–360. DOI: 10.1093/biomet/asq014.
  • Steingrimsson, J. A., Hanley, D. F., and Rosenblum, M. (2017), “Improving Precision by Adjusting for Prognostic Baseline Variables in Randomized Trials with Binary Outcomes, Without Regression Model Assumptions,” Contemporary Clinical Trials, 54, 18–24. DOI: 10.1016/j.cct.2016.12.026.
  • Ta, T., Shao, J., Li, Q., and Wang, L. (2020), “Generalized Regression Estimators with High-Dimensional Covariates,” Statistica Sinica, 30, 1135–1154. DOI: 10.5705/ss.202017.0384.
  • Taves, D. R. (1974), “Minimization: A New Method of Assigning Patients to Treatment and Control Groups,” Clinical Pharmacology and Therapeutics, 15, 443–453. DOI: 10.1002/cpt1974155443.
  • Tsiatis, A. A., Davidian, M., Zhang, M., and Lu, X. (2008), “Covariate Adjustment for Two-Sample Treatment Comparisons in Randomized Clinical Trials: A Principled yet Flexible Approach,” Statistics in Medicine, 27, 4658–4677. DOI: 10.1002/sim.3113.
  • Wang, B., Ogburn, E. L., and Rosenblum, M. (2019), “Analysis of Covariance in Randomized Trials: More Precision and Valid Confidence Intervals, Without Model Assumptions,” Biometrics, 75, 1391–1400. DOI: 10.1111/biom.13062.
  • Wang, B., Susukida, R., Mojtabai, R., Amin-Esmaeili, M., and Rosenblum, M. (2021), “Model-Robust Inference for Clinical Trials that Improve Precision by Stratified Randomization and Covariate Adjustment,” Journal of the American Statistical Association. DOI: 10.1080/01621459.2021.1981338.
  • White, H. (1980), “A Heteroskedasticity-Consistent Covariance Matrix Estimator and a Direct Test for Heteroskedasticity,” Econometrica, 48, 817–838. DOI: 10.2307/1912934.
  • Yang, L., and Tsiatis, A. A. (2001), “Efficiency Study of Estimators for a Treatment Effect in a Pretest–Posttest Trial,” The American Statistician, 55, 314–321. DOI: 10.1198/000313001753272466.
  • Yates, M., Mootoo, A., Adas, M., Bechman, K., Rampes, S., Patel, V., Qureshi, S., Cope, A. P., Norton, S., and Galloway, J. B. (2021), “Venous Thromboembolism Risk with Jak Inhibitors: A Meta-Analysis,” Arthritis and Rheumatology, 73, 779–788. DOI: 10.1002/art.41580.
  • Ye, T. (2018), “Testing Hypotheses Under Covariate-Adaptive Randomisation and Additive Models,” Statistical Theory and Related Fields, 2, 96–101. DOI: 10.1080/24754269.2018.1477005.
  • Ye, T., Yi, Y., and Shao, J. (2020), “Inference on Average Treatment Effect Under Minimization and Other Covariate-Adaptive Randomization Methods.” arXiv preprint arXiv:2007.09576.
  • Zelen, M. (1974), “The Randomization and Stratification of Patients to Clinical Trials,” Journal of Chronic Diseases, 27, 365–375. DOI: 10.1016/0021-9681(74)90015-0.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.